Skip to content
BMarker
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
Menu
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
  • NFLX vs GSK✓SelectedUSD · GSKNFLX vs GSK performance historyLatest closeAs of+0.23%11/18
Stock and ETF performance explorer

NFLX vs GSK

vs
1w1mo3mo6mo1y3y5y10yallcustom
Portfolio return
+419.2%
GSK return
+101.2%
Excess return
+318.1%
Maximum drawdown
-75.9%

Performance

Returns, benchmark comparison, and relative performance.

Performance by timeframe

Returns for 10y.

Portfolio and benchmark returns by period
PeriodPortfolioGSKExcessAlpha
1D+0.2%-1.3%+1.6%+0.6%
7D-7.3%-3.1%-4.2%-6.5%
30D-14.4%-0.9%-13.5%-14.2%
3M-23.1%-4.2%-18.9%-22.2%
6M-33.3%-1.6%-31.7%-33.1%
YTD-36.2%+2.6%-38.8%-37.0%
1Y-47.6%+6.2%-53.8%-48.8%
3Y+28.4%+55.0%-26.6%+8.3%
5Y-12.3%+42.8%-55.1%-25.0%
10Y+419.2%+102.1%+317.1%+279.1%
All+419.2%+101.2%+318.1%+279.1%

Cumulative growth

Daily Returns

Daily percentage return beside GSK.

Daily Out/Under-Performance

Portfolio return minus GSK return. Positive bars indicate outperformance.

Daily Alpha

Portfolio daily return minus β × GSK return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.

Cumulative Out/Under-Performance

Relative wealth over 10y: compounded portfolio wealth divided by compounded GSK wealth, less one. Both series rebase at the selected span's start.

Cumulative Alpha

Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.

Updating return analytics…

10y analysis · Full analysis span regression · 6 months rolling